BioSpace News Archive

Biotech Bay

AgeX Therapeutics CEO Michael D. West to Give Special Interview for The Economist’s Conference “The Business of Longevity: Health Innovation for an Ageing World” October 27 in Hong Kong

AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. , announced today that Chief Executive Officer Michael D. West, Ph.D., who also serves as Co- CEO of BioTime, is giving an interview as part of The Economist magazine’s conference.

October 26, 2017

·

3 min read

Business

Acceleron to Webcast Third Quarter 2017 Financial Results on November 7, 2017

Acceleron Pharma Inc. today announced it will host a webcast and conference call on Tuesday, November 7, 2017 at 8:00 a.m. EST to discuss its third quarter 2017 financial results and provide an update on recent clinical development and corporate activities.

October 26, 2017

·

1 min read

Drug Development

Vaxart Announces Positive Topline Results for Its Oral Tablet Vaccine in Phase II Influenza Challenge Study

Vaxart announced today that its H1 influenza oral tablet vaccine demonstrated similar protection against influenza virus as the market-leading injectable quadrivalent influenza vaccine (QIV) in a clinical trial.

October 26, 2017

·

4 min read

Alkermes Unveils Investigational Product Designed for Initiation Onto Aristada for Treatment of Schizophrenia

Alkermes plc unveiled Aripiprazole Lauroxil NanoCrystal Dispersion (ALNCD), a novel, investigational product designed for initiation onto ARISTADA (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia.

October 26, 2017

·

13 min read

Business

Lannett to Report Fiscal 2018 First-Quarter Financial Results, Host Conference Call On Monday, November 6

Lannett Company today announced that it will report financial results for its fiscal 2018 first quarter on Monday, November 6, 2017, after the market closes.

October 26, 2017

·

1 min read

Business

Alexion Reports Third Quarter 2017 Results

Alexion Pharmaceuticals, Inc. today announced financial results for the third quarter of 2017.

October 26, 2017

·

19 min read

Business

Excellent Results in Inhibiting Shingles Virus in Human Skin: NanoViricides Extends Agreement With SUNY Upstate Medical Center

NanoViricides announced today that it has extended its agreement with SUNY Upstate Medical Center for further testing of its nanoviricides drug candidates against varicella-zoster virus (VZV), the shingles virus, that causes debilitating infection of human skin.

October 26, 2017

·

3 min read

Business

West Announces Third-Quarter 2017 Results

West today announced its financial results for the third quarter of 2017, updated financial guidance for the full-year 2017, introduced sales growth outlook for full-year 2018 and reaffirmed long-term financial targets.

October 26, 2017

·

33 min read

Business

Spectrum Pharmaceuticals Announces Third Quarter 2017 Financial Results Teleconference and Webcast

Spectrum Pharmaceuticals today announced it will host a teleconference and webcast with management to discuss the third quarter 2017 financial results, provide an update on the Company’s business, and discuss expectations for the future.

October 26, 2017

·

3 min read

Drug Development

Alkermes to Initiate New Clinical Study Evaluating Aristada and Invega Sustenna for the Treatment of Schizophrenia

Alkermes plc today announced plans to initiate a phase 3b clinical study to evaluate the efficacy and safety of ARISTADA (aripiprazole lauroxil) extended-release injectable suspension and INVEGA SUSTENNA (paliperidone palmitate) in patients experiencing an acute exacerbation of schizophrenia.

October 26, 2017

·

13 min read